Odonate Therapeutics, Inc. Financial Ratios — ODTC Stock

Profitability (USD)

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-204.24	-31.73	-51.4	-67.47	-70.84	-55.34	47	6.84
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-0.59
Gross Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	22.44
Dvd Payout Ratio (%)	- -	-25.64	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Total Debt	- -	- -	- -	- -	2	5	5	3	2
ST Debt	- -	- -	- -	- -	- -	1	1	- -	1
LT Debt	- -	- -	- -	- -	2	5	4	2	2
Total Debt/EBITDA	- -	- -	- -	- -	-0.02	-0.04	-0.07	-0.73	-2.89
Net Debt/EBITDA	0.87	0.84	6.05	1.54	1.58	1.24	1.01	2.82	49.68
Total Debt/EBIT	- -	- -	- -	- -	-0.02	-0.04	-0.07	-0.71	-2.81
Net Debt/EBIT	0.87	0.84	6.05	1.53	1.57	1.23	1.01	2.74	48.4
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	79.29	-223.74	-19.19	-89.72	-126.98	-218.04	-549.98	-377.44	-348.09
Long-Term Debt/Equity (%)	- -	- -	- -	- -	1.08	3.43	6.59	2.28	1.66
Long-Term Debt/Capital (%)	- -	- -	- -	- -	-0.74	-1.29	-0.91	-0.59	-0.47
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	0.93	2.78	4.94	2.22	1.63
Total Debt/Equity (%)	- -	- -	- -	- -	1.27	3.91	7.87	2.74	2.13
Total Debt/Capital (%)	- -	- -	- -	- -	-0.87	-1.48	-1.09	-0.71	-0.6
Total Debt/Total Assets (%)	- -	- -	- -	- -	1.09	3.17	5.91	2.67	2.08
Net Debt to Equity	-124.32	-113.84	-101.08	-112.13	-111.19	-115.51	-116.25	-10.63	-36.57
Net Debt/Capital (%)	511.11	28.73	83.53	52.07	43.15	30.36	13.81	2.68	9.38
EBITDA	- -	-3	-33	-90	-115	-127	-68	-4	-1
EBITDA-CapEx	- -	-3	-33	-92	-115	-127	-68	-4	-1
Operating Income (Loss)	- -	-3	-33	-91	-115	-127	-68	-4	-1

Liquidity (USD)

API Chat

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Cash Ratio	4.76	4.35	26.37	7.64	7.28	5.81	4.35	82.54	111.58
Current Ratio	4.83	4.79	27.02	7.68	7.42	5.91	4.75	82.66	111.72
Quick Ratio	4.76	4.35	26.37	7.64	7.28	5.81	4.35	82.54	111.58
CFO/Avg Current Liab	- -	-5.53	-6.38	-5.22	-4.5	-4.36	-3.53	0.22	15.96
Common Equity/Total Assets	79.29	-223.74	-19.19	-89.72	-126.98	-218.04	-549.98	-377.44	-348.09
Long-Term Debt/Equity (%)	- -	- -	- -	- -	1.08	3.43	6.59	2.28	1.66
Long-Term Debt/Capital (%)	- -	- -	- -	- -	-0.74	-1.29	-0.91	-0.59	-0.47
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	0.93	2.78	4.94	2.22	1.63
Total Debt/Equity (%)	- -	- -	- -	- -	1.27	3.91	7.87	2.74	2.13
Total Debt/Capital (%)	- -	- -	- -	- -	-0.87	-1.48	-1.09	-0.71	-0.6
Total Debt/Total Assets (%)	- -	- -	- -	- -	1.09	3.17	5.91	2.67	2.08
CFO/Total Liabilities	-568.97	-289.8	-344.22	-359.39	-364.3	-356.42	-383.79	62.26	374.79
CFO/CapEx	- -	- -	-311.54	-35.18	-582.16	-261.88	-2,912.5	- -	- -
Altman's Z-Score	-37.4	-5.77	54.03	9.76	20.71	9.38	-8.08	-4.86	-4.28

Working Capital (USD)

API Chat

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Market Capitalization	- -	- -	672	376	1,038	740	52	- -	- -
- Cash & Cash Equivalents	- -	3	198	139	180	157	69	11	40
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	2	5	5	3	2
Enterprise Value	- -	-3	474	237	860	588	-12	-45	-55
Total Capital	- -	-6	-39	-128	-238	-361	-430	-389	-382
Total Debt/Capital (%)	- -	- -	- -	- -	-0.87	-1.48	-1.09	-0.71	-0.6
Total Debt / EV	- -	- -	- -	- -	- -	0.01	-0.38	-0.06	-0.04
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	672	376	1,038	740	52	- -	- -
Diluted Enterprise Value	- -	-3	474	237	860	588	-12	-8	-37
EV per Share	- -	- -	1,410,401.79	710,082.63	2,150,007.5	1,220,773.86	- -	- -	- -
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	- -	-3	-33	-90	-115	-127	-68	-4	-1
TTM Operating Income	- -	-3	-33	-91	-115	-127	-68	-4	-1
TTM Cash Flow to Firm	- -	-2	-26	-67	-97	-113	-76	2	9
TTM Free Cash Flow to Firm	- -	-2	-26	-65	-96	-113	-76	2	9

Multiples (USD)

API Chat

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Price/Free Cash Flow	- -	- -	-26.07	-5.77	-10.76	-6.57	-0.69	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	-3	474	237	860	588	-12	-45	-55
Low Price	- -	- -	1,784,800	923,200	1,035,200	1,004,800	104,800	64,616	120,000
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-19.4	-6.22	-7.61	-8.02	-3.87	- -	- -
Price/Earnings High	- -	- -	-20.82	-9.61	-12.52	-14.19	-16	- -	- -
Price/Earnings Low	- -	- -	-18.31	-3.47	-3.7	-3.83	-0.74	- -	- -
Price/Book Value	- -	- -	-17.21	-2.94	-4.33	-2.02	-0.12	- -	- -
Price/Book Value Average	- -	- -	-16.26	-4.32	-3.55	-2.77	-0.61	- -	- -
Price/Book Value High	- -	- -	-17.46	-6.68	-5.84	-4.9	-2.52	- -	- -
Price/Book Value Low	- -	- -	-15.36	-2.41	-1.73	-1.32	-0.12	- -	- -
Price/Tangible Book Value	- -	- -	3.43	3.03	6.4	5.44	0.88	- -	- -
Price/Tangible Book Value Average	- -	- -	3.24	4.46	5.24	7.44	4.47	- -	- -
Price/Tangible Book Value High	- -	- -	3.48	6.9	8.63	13.17	18.45	- -	- -
Price/Tangible Book Value Low	- -	- -	3.06	2.49	2.55	3.56	0.85	- -	- -
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow	- -	- -	-25.99	-5.61	-10.75	-6.54	-0.69	- -	- -
Price/Cash Flow Average	- -	- -	-24.56	-8.24	-8.81	-8.96	-3.5	- -	- -
Price/Cash Flow High	- -	- -	-26.37	-12.74	-14.49	-15.85	-14.44	- -	- -
Price/Cash Flow Low	- -	- -	-23.19	-4.6	-4.28	-4.28	-0.67	- -	- -
Price/Free Cash Flow Average	- -	- -	-24.64	-8.48	-8.82	-8.99	-3.5	- -	- -
Price/Free Cash Flow High	- -	- -	-26.45	-13.12	-14.51	-15.91	-14.44	- -	- -
Price/Free Cash Flow Low	- -	- -	-23.27	-4.73	-4.29	-4.3	-0.67	- -	- -
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	0.87	0.84	-13.35	-4.58	-5.87	-6.78	-2.95	2.09	46.79
EV/EBITDA High	0.87	0.84	-14.78	-7.92	-10.67	-12.92	-15.13	2.09	46.79
EV/EBITDA Low	0.87	0.84	-12.27	-1.87	-2.06	-2.62	0.2	2.09	46.79
EV/EBIT Average	0.87	0.84	-13.35	-4.56	-5.85	-6.76	-2.93	2.03	45.59
EV/EBIT High	0.87	0.84	-14.77	-7.89	-10.63	-12.88	-15.03	2.03	45.59
EV/EBIT Low	0.87	0.84	-12.26	-1.87	-2.05	-2.61	0.2	2.03	45.59
Last Price	- -	- -	2,000,000	1,126,400	2,596,000	1,536,000	108,000	140,000	120,000
High Price	- -	- -	2,029,200	2,560,000	3,500,000	3,719,992	2,272,800	158,400	193,600
Enterprise Value Average	- -	-3	437	414	673	861	200	-8	-37
Enterprise Value High	- -	-3	484	716	1,222	1,641	1,029	-8	-37
Enterprise Value Low	- -	-3	402	169	236	332	-14	-8	-37

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Shares Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA per Share	-470.24	-9,181.55	-97,392.86	-270,700.6	-286,260	-263,460.58	-141,388.77	- -	- -
Operating Income per Share	-470.24	-9,181.55	-97,452.38	-271,748.5	-287,325	-264,383.82	-142,380.46	- -	- -
Basic EPS, GAAP	-470.24	-9,181.55	-97,452.38	-266,347.31	-279,562.5	-262,136.93	-142,027.03	- -	- -
Basic EPS from Cont Ops	-470.24	-9,181.55	-97,452.38	-266,347.31	-279,562.5	-262,136.93	-142,027.03	- -	- -
Diluted EPS, GAAP	-470.24	-9,181.55	-97,452.38	-266,347.31	-279,562.5	-262,136.93	-142,027.03	- -	- -
Diluted EPS from Cont Ops	-470.24	-9,181.55	-97,452.38	-266,347.31	-279,562.5	-262,136.93	-142,027.03	- -	- -
Dividend per Share	- -	2,354.17	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-491.07	-5,157.74	-76,958.33	-200,880.24	-241,595	-234,709.54	-157,432.43	- -	- -
Free Cash Flow per Basic Share	-491.07	-5,157.74	-77,205.36	-206,589.82	-242,010	-235,605.81	-157,486.49	- -	- -
Cash & Equivalents per Share	410.71	7,735.12	589,598.21	416,317.37	451,150	326,275.93	143,226.61	- -	- -
Book Value per Share	330.36	-19,184.52	-116,226.19	-383,257.49	-599,442.5	-759,460.58	-903,234.93	- -	- -
Tangible Book Value per Share	330.36	6,794.64	583,279.76	371,269.46	405,750	282,458.51	123,209.98	- -	- -

Odonate Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)